OMERS Administration Corp’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-18,000
Closed -$1.01K – 364
2023
Q3
$1.01K Hold
18,000
– – ﹤0.01% 210
2023
Q2
$2.46K Hold
18,000
– – ﹤0.01% 174
2023
Q1
$1.54K Hold
18,000
– – ﹤0.01% 257
2022
Q4
$828 Hold
18,000
– – ﹤0.01% 311
2022
Q3
$3K Hold
18,000
– – ﹤0.01% 296
2022
Q2
$2K Hold
18,000
– – ﹤0.01% 400
2022
Q1
$4K Buy
+18,000
New +$4.67K ﹤0.01% 429

OMERS Administration Corp's BIOSW Position: Q4 2023 in Review

OMERS Administration Corp sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 18,000 shares — an estimated $1.01K sold.

OMERS Administration Corp first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $4K in Q1 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

  • OMERS Administration Corp reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
  • OMERS Administration Corp sold 18,000 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $1.01K.
  • OMERS Administration Corp first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
  • OMERS Administration Corp's BioPlus Acquisition Corp. Warrants position peaked at $4K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on OMERS Administration Corp's 13F filing for Q4 2023, filed 13 Feb 2024.